Contract facts
UnrestrictedA PHASE 1 PLACEBO-CONTROLLED DOSE-ESCALATION SAFETY AND PHARMACOKINETIC STUDY OF IN-007, A NEBULIZED, PAN-SARS ACE2-DECOY THERAPEUTIC FOR PANDEMIC PREPAREDNESS is a federal Unrestricted award for Army Med Res Acq Activity held by Inhalon Biopharma, Inc. Estimated value $3.2M ($3.2M obligated). Current period of performance ends Dec 31, 2027. Last award drew 44 bidders. Place of performance: MORRISVILLE NC. Related solicitation HT942524SJWMR.
A PHASE 1 PLACEBO-CONTROLLED DOSE-ESCALATION SAFETY AND PHARMACOKINETIC STUDY OF IN-007, A NEBULIZED, PAN-SARS ACE2-DECOY THERAPEUTIC FOR PANDEMIC PREPAREDNESS
Recompete timing
PublicCurrent PoP ends Dec 31, 2027 (460 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Want the durability read on HT942525CE039? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordInhalon Biopharma, Inc — $5.4M obligated across 2 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942525CE039?
HT942525CE039 (PHASE 1 placebo-controlled dose-escalation) is a Army Med Res Acq Activity award with a potential value of $3.2M, currently held by Inhalon Biopharma, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HT942525CE039?
Army Med Res Acq Activity awarded HT942525CE039 to Inhalon Biopharma, Inc (potential $3.2M).
Who is the incumbent on HT942525CE039?
Inhalon Biopharma, Inc is the incumbent with $5.4M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2027.
When does Inhalon Biopharma, Inc’s HT942525CE039 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT942525CE039? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.